Tissue repair biological material, preparation method and application thereof, and rotator cuff injury repair product
Through ROS response to the biomaterial of hydrogel and nanofiber membrane, the problem of difficulty in healing the tendon-bone interface after rotator cuff tear is solved, and the continuous repair of rotator cuff injury is achieved by regulating the immune environment and sustained release of cell exosomes. Regeneration of bone and cartilage.
Patent Information
- Application Number
- CN202411072158.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-06
AI Technical Summary
The tendon-bone interface after rotator cuff tear is difficult to heal, and the existing patches cannot effectively solve the inflammatory microenvironment and cell regeneration problems, resulting in a high rate of retearing after surgery.
Using biomaterials of ROS-responsive hydrogels and nanofiber membranes, ROS-responsive hydrogels contain M2 macrophage exosomes and perfluoromic compounds. The nanofiber membrane is composed of bone marrow mesenchymal stem cell exosomes, through Regulates the immune environment and sustained release of cellular exosomes to promote bone and cartilage regeneration.
Effectively reduce oxygen free radical pressure, regulate immune imbalance, inhibit infiltration of inflammatory factors, create a bone and cartilage regeneration environment, and achieve continuous repair of rotator cuff injury.
Smart Images

Figure CN118987341A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, and in particular to a tissue repair biomaterial, a preparation method and application, and a rotator cuff injury repair product. Background Art
[0002] The following statements merely provide background information related to the present disclosure and do not necessarily constitute prior art.
[0003] Perfect repair of rotator cuff tears remains a difficult problem in the field of sports medicine. Arthroscopic rotator cuff repair is currently the main method for treating rotator cuff tears, but the high rate of postoperative re-tear is a clinical pain point. Commonly used rotator cuff repair patches can provide mechanical assistance to the damaged rotator cuff tissue, and the improvement of surgical techniques can also help restore the anatomical structure of the rotator cuff injury area, but it is still difficult to repair the damage to the tendon-bone interface after rotator cuff tear at the microscopic level, especially the damage to the bone and cartilage transition zone in the interface - the fibrocartilage zone.
[0004] The difficulty in healing the tendon-bone interface after rotator cuff tear is due to a complex pathological process. Studies have found that the tendon-bone interface after injury has manifestations of immune imbalance such as persistent chronic inflammatory infiltration and increased oxygen free radical pressure, and endogenous bone and cartilage cells are difficult to regenerate and repair under the inflammatory microenvironment. In view of such a complex pathological process, the patches currently available on the market cannot solve it well. With the development of tissue engineering and biomaterials, new biomaterials combined with bioactive substances (cells, drugs or organelles) are a hot topic of research. New materials provide a good delivery medium for therapeutic media. However, the application of bioactive substances also has problems such as high immunogenicity, poor targeting, and short action time.
[0005] In view of this, the present invention is proposed. Summary of the invention
[0006] The purpose of the present invention is to provide a tissue repair biomaterial with the advantages of low immunogenicity and good targeting, which can achieve the spatiotemporal treatment purpose of first regulating the immune inflammatory microenvironment and then continuously promoting bone and cartilage regeneration. The second purpose of the present invention is to provide a rotator cuff injury repair product based on the above-mentioned tissue repair biomaterial, which can continuously promote bone and cartilage regeneration.
[0007] In order to solve the above technical problems, the present invention particularly adopts the following technical solutions:
[0008] In a first aspect, a tissue repair biomaterial is provided, comprising a ROS-responsive hydrogel and a nanofiber membrane, wherein the ROS-responsive hydrogel is coated on the surface of the nanofiber membrane;
[0009] The ROS-responsive hydrogel comprises a hydrogel and first nanoparticles dispersed in the hydrogel; the first nanoparticles are microspheres in which second nanoparticles and peroxidase are encapsulated by liposomes; the second nanoparticles are microspheres containing M2 macrophage exosomes and perfluorochemicals, and the shell of the second nanoparticles comprises a lactic acid-glycolic acid copolymer and a polysulfide;
[0010] The fibers constituting the nanofiber membrane are of a core-shell structure, and the core layer contains exosomes derived from bone marrow mesenchymal stem cells.
[0011] In a second aspect, a method for preparing the tissue repair biomaterial according to the first aspect is provided, comprising:
[0012] (A) mixing a perfluorochemical solution containing M2 macrophage exosomes with a lactic acid-glycolic acid copolymer and a polysulfide, emulsifying and ultrasonicating to form a water-in-oil-in-water double emulsion, separating and collecting the second nanoparticles formed in the system; preparing liposomes containing catalase by a thin film dispersion method, and then mixing and incubating with the second nanoparticles to obtain the first nanoparticles;
[0013] (B) loading exosomes onto hydrosol nanoparticles, dispersing the hydrosol nanoparticles loaded with exosomes into an electrospinning solution, and obtaining a nanofiber membrane with a core-shell structure by electrospinning, wherein the hydrosol nanoparticles are composed of the water-soluble polymer in the aqueous medium;
[0014] (C) mixing the first nanoparticles prepared in step (A) with the hydrogel, and then placing the nanofiber membrane in the hydrogel to obtain a nanofiber membrane coated with the ROS-responsive hydrogel.
[0015] In a third aspect, there is provided application of the tissue repair biomaterial of the first aspect or the preparation method of the second aspect in the preparation of tissue or organ damage repair products.
[0016] In a fourth aspect, a rotator cuff injury repair product is also provided, wherein the rotator cuff injury repair product comprises (i) or (ii):
[0017] (i) the tissue repair biomaterial of the first aspect;
[0018] (ii) The ROS responsive hydrogel described in the first aspect, and the nanofibrous membrane described in the first aspect.
[0019] Compared with the prior art, the present invention has the following beneficial effects:
[0020] The ROS-responsive hydrogel part loaded with M2 macrophage exosomes in the tissue repair biomaterial provided by the present invention responds to the oxygen free radical high pressure environment after being implanted in the damaged interface, and releases the M2 macrophage exosomes in the hydrogel as a switch. On the one hand, the ROS-responsive hydrogel reduces the oxygen free radical pressure at the damaged interface by binding to ROS, and the M2 macrophage exosomes play a role in regulating immunity by inducing the transformation of M1 macrophages to M2 macrophages. At the same time, the M2 macrophage exosomes can inhibit the secretion of inflammatory factors by M1 macrophages and inhibit inflammatory infiltration. Subsequently, the nanofiber membrane slowly releases exosomes derived from bone marrow mesenchymal stem cells, which plays a role in continuously promoting cell regeneration at the damaged site. This tissue repair biomaterial can target the pathophysiological characteristics of local immune imbalance, increased oxygen free radical pressure, and infiltration of inflammatory factors after rotator cuff injury. It can effectively target the time sequence of the pathological process of rotator cuff injury, innovatively achieve the priority reduction of oxygen free radical pressure, regulate the immune imbalance environment, and inhibit the infiltration of inflammatory factors to create an environment for subsequent bone and cartilage repair. As a rotator cuff injury repair product, it can continuously promote bone and cartilage regeneration.
[0021] The rotator cuff injury repair product using the above-mentioned tissue repair biomaterials firmly grasps the fundamental factor of immune imbalance in the injured area (mainly manifested as increased oxygen free radical pressure and inflammatory infiltration), focuses on the fundamental problem of endogenous cell repair dysfunction, and adopts the treatment concept of first regulating the immune system to suppress inflammation and then continuously promoting cartilage regeneration. The two new biomaterials are combined with exosomes with low immunogenicity, good targeting, and multi-phase therapeutic functions, which achieves the purpose of regulating the immune inflammatory microenvironment and continuously promoting cartilage regeneration. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0023] Figure 1 , Figure 2 and Figure 3 A photo of the ROS-responsive hydrogel prepared in Example;
[0024] Figure 4 This is an electron microscope photo of the rice fiber membrane prepared in Example;
[0025] Figure 5 The expression levels of RUX2, ALP, COL1A1 and OCN genes in C3H10 cells at different time points after the rotator cuff patch prepared in the example was co-cultured with C3H10 cells. DETAILED DESCRIPTION
[0026] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0027] In a first aspect, a tissue repair biomaterial is provided. The tissue repair biomaterial comprises a ROS responsive hydrogel and a nanofiber membrane, wherein the ROS responsive hydrogel is coated on the surface of the nanofiber membrane.
[0028] The ROS-responsive hydrogel includes a hydrogel and first nanoparticles dispersed in the hydrogel; the first nanoparticles are microspheres in which second nanoparticles and peroxidase are encapsulated by liposomes; the second nanoparticles are microspheres containing M2 macrophage exosomes (M2-exo) and perfluorochemicals (PFCs), and the shell of the second nanoparticles includes poly(lactic acid-glycolic acid) (PLGA) and polysulfide (PPS).
[0029] The perfluorinated compound in this article refers to Perfluoro-15-crown-5-ether (CAS: 97571-69-2), referred to as PFC. PFC has high oxygen solubility and good biocompatibility. It can be used as an oxygen carrier to achieve oxygen supply to the bone defect area and responsive release of ROS in hydrogel. Nanoparticles containing it have ROS scavenging and continuous oxygen generation functions, which can improve the hypoxic microenvironment and promote tissue repair and regeneration.
[0030] In an optional embodiment, the M2 macrophage exosomes are derived from the macrophage cell line Thp-1 (human monocytic leukemia) or RAW264.7 (mouse monocytic macrophage leukemia cells).
[0031] In an optional embodiment, the particle size of the second nanoparticles is 150 to 200 nm.
[0032] In an alternative embodiment, the peroxidase comprises catalase (CAT).
[0033] In an alternative embodiment, the hydrogel comprises methacryloyl gelatin hydrogel (GelMA).
[0034] In an optional embodiment, the liposome is composed of phosphatidylcholine (SPC), cholesterol and distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG2000).
[0035] In an optional embodiment, the first nanoparticles are prepared according to the following method:
[0036] A perfluorinated compound solution containing M2 macrophage exosomes is mixed with a lactic acid-glycolic acid copolymer and a polysulfide, emulsified and ultrasonically treated to form a water-in-oil-in-water double emulsion, and the second nanoparticles formed in the system are separated and collected; liposomes containing catalase are prepared by a thin film dispersion method, and then mixed and incubated with the second nanoparticles to obtain the first nanoparticles.
[0037] The fibers in the nanofiber membrane of the tissue repair biomaterial are of a core-shell structure, and the core layer of the fibers contains exosomes derived from bone marrow mesenchymal stem cells (BMSCs-exo).
[0038] In an optional embodiment, the nanofiber membrane is an electrospun nanofiber membrane.
[0039] In an optional embodiment, the exosomes of the bone marrow mesenchymal stem cells are modified with cholesterol and chondrocyte targeting peptides. Cholesterol molecules can be embedded in the phospholipid membrane of the exosomes due to their lipophilicity, while the chondrocyte targeting peptides have the ability to specifically bind to chondrocytes. By attaching these molecules to the surface of the exosomes, the exosomes can be made to have the ability to target chondrocytes in in vivo or in vitro experiments.
[0040] In an optional embodiment, the targeting of bone marrow mesenchymal stem cell exosomes is increased by using a CAP lipid anchor kit.
[0041] In an optional embodiment, the core layer of the electrospun nanofiber membrane contains a water-soluble polymer loaded with mesenchymal stem cell-derived exosomes.
[0042] In an optional embodiment, the water-soluble polymer includes hyaluronic acid.
[0043] In an alternative embodiment, the shell layer of the electrospun nanofiber membrane contains poly-L-lactic acid (PLLA) and N,N-dimethylformamide (DMF).
[0044] In an optional embodiment, the electrospun nanofiber membrane is prepared according to the following method: exosomes are loaded on hydrosol nanoparticles, and the hydrosol nanoparticles loaded with exosomes are dispersed in an electrospinning solution, and an electrospun fiber membrane with a core-shell structure is obtained by electrospinning; the hydrosol nanoparticles are composed of the water-soluble polymer in the aqueous medium.
[0045] The ROS-responsive hydrogel part loaded with M2 macrophage exosomes in the tissue repair biomaterial provided by the present invention responds to the high-pressure environment of oxygen free radicals after being implanted into the damaged interface, and acts as a switch to release the M2 macrophage exosomes in the hydrogel. There are high concentrations of oxygen free radicals at the damaged interface. When the oxygen free radicals come into contact with the ROS-responsive hydrogel, the peroxidase in the first nanoparticle catalyzes ROS, triggering a change in the hydrophilicity of PPS. In the ROS environment, the sulfide part in the PPS central block is solidified, which eventually destroys the morphology of the second nanoparticle and releases the M2 macrophage exosomes and perfluorinated compounds therein. The ROS-responsive hydrogel reduces the oxygen free radical pressure at the damaged interface by binding to ROS, and the M2 macrophage exosomes play a role in regulating immunity by inducing the transformation of M1 macrophages to M2 macrophages. At the same time, the M2 macrophage exosomes can inhibit the secretion of inflammatory factors by M1 macrophages and inhibit inflammatory infiltration. The nanofiber membrane then slowly releases exosomes derived from mesenchymal stem cells, which continuously promotes cell regeneration at the injured site, and the nanofiber membrane also provides mechanical strength for the tissue repair biomaterial. The tissue repair biomaterial provided by the present invention is particularly suitable for rotator cuff injuries and can effectively target the time sequence of the pathological process of rotator cuff injuries.
[0046] In a second aspect, a method for preparing the tissue repair biomaterial in the first aspect is also provided, comprising:
[0047] (A) mixing a perfluorochemical solution containing M2 macrophage exosomes with a lactic acid-glycolic acid copolymer and a polysulfide, emulsifying and ultrasonicating to form a water-in-oil-in-water double emulsion, separating and collecting the second nanoparticles formed in the system; preparing liposomes containing catalase by a thin film dispersion method, and then mixing and incubating with the second nanoparticles to obtain the first nanoparticles;
[0048] (B) loading exosomes onto hydrosol nanoparticles, dispersing the hydrosol nanoparticles loaded with exosomes into an electrospinning solution, and obtaining a nanofiber membrane with a core-shell structure by electrospinning, wherein the hydrosol nanoparticles are composed of the water-soluble polymer in the aqueous medium;
[0049] (C) mixing the first nanoparticles prepared in step (A) with the hydrogel, and then placing the nanofiber membrane in the hydrogel to obtain a nanofiber membrane coated with the ROS-responsive hydrogel.
[0050] In an optional embodiment, the step (B) comprises emulsifying hyaluronic acid and exosomes of bone marrow mesenchymal stem cells into an oil-in-water emulsion, adding poly-L-lactic acid and N,N-dimethylformamide to the emulsion to obtain an electrospinning solution. During electrospinning, the hydrosol nanoparticles loaded with exosomes dispersed in the electrospinning solution aggregate to form a core layer to obtain the nanofiber membrane with a core-shell structure.
[0051] In an optional embodiment, the electrospinning conditions include: a spinning voltage of 12 kV, which can produce a stable jet stream; a spinning needle diameter of 0.9 mm, a spinning solution flow rate of 0.8 mL / h, which can ensure the continuity and stability of the spinning solution; and a receiving distance of 15 cm, which helps to form uniform fiber deposition.
[0052] In an optional implementation, the nozzle rotation speed is 200 to 1600 rpm.
[0053] In a third aspect, there is provided application of the tissue repair biomaterial of the first aspect or the preparation method of the second aspect in the preparation of tissue or organ damage repair products.
[0054] In a fourth aspect, a rotator cuff injury repair product is provided, wherein the rotator cuff injury repair product comprises (i) or (ii):
[0055] (i) The tissue repair biomaterial of the first aspect.
[0056] (ii) The hydrogel containing the first nanoparticles of the first aspect and the nanofiber membrane of the first aspect, when used, the hydrogel containing the nanoparticles is coated on the surface of the nanofiber membrane and applied to the affected area.
[0057] In an optional embodiment, the rotator cuff injury repair product includes a rotator cuff patch.
[0058] The rotator cuff injury repair product using the above-mentioned tissue repair biomaterials firmly grasps the fundamental factor of immune imbalance in the injured area (mainly manifested as increased oxygen free radical pressure and inflammatory infiltration), focuses on the fundamental problem of endogenous cell repair dysfunction, and adopts the treatment concept of first regulating the immune system to suppress inflammation and then continuously promoting cartilage regeneration. The two new biomaterials are combined with exosomes with low immunogenicity, good targeting, and multi-phase therapeutic functions, which achieves the purpose of regulating the immune inflammatory microenvironment and continuously promoting cartilage regeneration.
[0059] The present invention is further described below by means of specific examples. However, it should be understood that these examples are only used for more detailed description and should not be construed as limiting the present invention in any form.
[0060] Example
[0061] Main reagents:
[0062] RAW264.7: Acmec product number: AC15883-bottle; Phorbol Myristate Acetate (PMA): Acmec product number: PMA-P33390-1mg; IFN-y: Sigma-Aldrich02-0320-00; LPS: Acmec LPS-AC12037-100mg; IL-4: Acmec AC13064-10μg; FBS: Acmec AS9010-100ml; 1640: Acmec 1640-A10491-500ml; PBS: Acmec PBS-AC13317-500ml; DMEM: Acmec DMEM-A12100S-500ml; SD rats: Spafford; PLGA: Acmec P39480-1g; PFC330: Miaoling Bio P13291; PPS: Acmec X67155-1ml.
[0063] Preparation of CAT@Lip:
[0064] 1. Soybean phosphatidylcholine: Acmec; 2. L51990-100mg; 3. Cholesterol: Acmec C70092-200mg; DSPE-PEG2000: ruixibio R-1028-2K; PFC330: Miaoling Bio P13291.
[0065] CAP lipid anchor kit: Lipid Anchor Kit Catalog No. EA-17-1.
[0066] 1. Preparation and extraction of macrophage exosomes
[0067] (1) Preparation method of macrophage-derived exosomes: Macrophage culture and differentiation: Using the RAW cell line, M0 macrophages were generated by treating with 200 nM Phorbol Myristate Acetate (PMA) for 6 hours, and then interferon-γ (IFN-γ) and lipopolysaccharide (LPS) or interleukin-4 (IL-4) / IL-13 were used to induce the differentiation of M1 and M2 macrophages, respectively.
[0068] (2) Collection of exosomes: After macrophage differentiation, the culture medium was replaced with RPMI 1640 medium supplemented with fetal bovine serum (FBS) that had been depleted of exosomes, and the culture was continued for 48 hours.
[0069] (3) Initial centrifugation: The culture medium was centrifuged at 2000 g for 20 min to remove debris and dead cells, and then ultracentrifuged at 100,000 g for 90 min to collect exosomes.
[0070] (4) Washing and re-ultracentrifugation: The exosome pellet was washed with phosphate-buffered saline (PBS), then ultracentrifuged again at 100,000 g for 90 min and resuspended in PBS.
[0071] 2. Preparation and extraction of exosomes from bone marrow mesenchymal stem cells
[0072] (1) Extraction and culture of bone marrow mesenchymal stem cells: BMSCs were extracted from the femur and tibia of 5-week-old Sprague-Dawley (SD) rats and then cultured in DMEM medium containing 10% FBS.
[0073] (2) Collection of exosomes: When the BMSCs confluence rate reached 80%, the medium was replaced with FBS medium without exosomes and cultured for another 48 hours. Afterwards, the medium was collected and subjected to a series of centrifugation steps, including centrifugation at 300×g and 2000×g, to remove cells and cell debris.
[0074] (3) Ultrafiltration and ultracentrifugation: Filter using a 0.22 μm filter, then centrifuge at 4000×g in an Amicon ultrafiltration device to reduce the volume to approximately 200 μL. Wash twice with PBS, and then ultrafilter to 200 μL.
[0075] (4) Density gradient centrifugation: The filtrate was placed on 30% sucrose / D2O buffer and centrifuged at 100,000×g for 60 minutes using an ultracentrifuge.
[0076] (5) Collection and storage of exosomes: The precipitate containing BMSC-Exos was collected using an 18-G needle, diluted with PBS, and centrifuged at 4000 × g in a centrifugal filter unit to a final volume of 200 μL. BMSC-Exos were stored at −80°C.
[0077] (6) Use the CAP lipid anchor kit to increase the targeting of bone marrow mesenchymal stem cell exosomes and follow the instructions of the kit. The CAP lipid anchor kit achieves cartilage targeting of exosomes by using specific lipid anchor molecules. These lipid anchor molecules contain cholesterol and chondrocyte targeting peptides (CAP) labeled with fluorescein (FITC). Cholesterol molecules can be embedded in the phospholipid membrane of exosomes due to their lipophilicity, while CAP peptides have the ability to specifically bind to chondrocytes. By attaching these molecules to the surface of exosomes, exosomes can be made to have the ability to target chondrocytes in in vivo or in vitro experiments.
[0078] 3. Preparation of ROS-responsive hydrogels containing M2 macrophage exosomes (M2-exo) (Part 1)
[0079] (1) Synthesis of M2-exo / PFC@PLGA / PPS nanoparticles: Nanoparticles containing M2-exo and PFC were prepared using a double emulsion (water / oil / water) solvent evaporation method. 11 PFC solution (20 μL) of M2-exo (M2 macrophage-derived exosomes prepared in the above steps) was mixed with PLGA / PPS (2.4 mg, W / W=1:1) and dissolved in dichloromethane (100 μL), and then 1 mL of 5% w / v PVA (polyvinyl alcohol) solution was added, and the mixture was sonicated in an ice-water bath for 5 minutes using an ultrasonic processor equipped with a micro-needle tip. Then 0.6 mL of PVA solution was added to homogenize the emulsion. The product was then centrifuged at 14800 rpm at 4°C for 10 minutes and washed several times with purified water to remove PVA. M2-exo / PFC@PLGA / PPS nanoparticles were collected and stored in deionized water.
[0080] (2) Synthesis of CAT-PFC@PLGA / PPS@Lip nanoparticles (CPP-L): CAT-loaded liposomes containing SPC, cholesterol and DSPE-PEG2000 were prepared using a thin film dispersion method. Each component was dissolved in chloroform at a molar ratio of 10:1:3, the chloroform was removed by drying, and a thin lipid film was obtained. The film was dispersed in 2 mL phosphate buffered saline (PBS) containing 3 mg CAT for hydration to form CAT-liposomes. M2-exo / PFC@PLGA / PPS was incubated with CAT-liposomes at 4°C overnight, and CPP-L nanoparticles were collected by centrifugation.
[0081] (3) CPP-L nanoparticles are added to a GelMA solution containing a photoinitiator, and the hydrogel solution is cross-linked by ultraviolet light to form a ROS-responsive hydrogel. The prepared hydrogel is as follows Figure 1 , Figure 2 and Figure 3 shown.
[0082] 4. Preparation of electrospinning of bone marrow mesenchymal stem cell-loaded exosomes (BMSCs-exo) (part 2)
[0083] (1) Preparation of microsol solution: First, drug-containing hyaluronic acid (HA) microsol nanoparticles were prepared by ultrasonic emulsification.
[0084] Take 100 mg of HA and BMSCs-exo (concentration of 10×10 11 particles / ml).
[0085] Add HA and BMSCs-exo to a solution containing 3 ml of dichloromethane (DCM) and add 1% Span-80 as a surfactant (100 mg of PLLA, then 1 mg of Span-80). Stir vigorously for 25 minutes to form a uniform water-in-oil (W / O) emulsion. Make sure the stirring speed is high enough to form fine emulsion droplets. Add PLLA (200 mg) and N,N-dimethylformamide (4 mL) to the emulsion until completely dissolved. The amount of PLLA and DMF should be adjusted according to the viscosity and conductivity of the final electrospinning solution to ensure good electrospinning performance.
[0086] (2) Electrospinning process: Using an electrospinning device, the electrospinning solution was transferred to a 10 mL syringe, the voltage was set to 12 kV, and applied through a needle with a diameter of 0.9 mm. The flow rate of the electrospinning solution was set to 0.9 mL / h, and the electrospun fibers were collected on a grounded aluminum foil 15 cm away from the needle. Nanofiber membranes were prepared at nozzle speeds of 200 rpm, 400 rpm, 600 rpm, 800 rpm, 1000 rpm, 1200 rpm, 1400 rpm, and 1600 rpm, respectively.
[0087] (3) Characterization of fiber membrane: Field emission scanning electron microscopy (FESEM) and transmission electron microscopy (TEM) were used to observe the morphology and internal structure of the fiber membrane. Figure 4 shown. Figure 4 1 to 8 are nanofiber membranes prepared at nozzle speeds of 200 rpm, 400 rpm, 600 rpm, 800 rpm, 1000 rpm, 1200 rpm, 1400 rpm and 1600 rpm, respectively.
[0088] 5. Preparation of rotator cuff patch:
[0089] CPP-L nanoparticles were added to the GelMA solution containing a photoinitiator, the hydrogel solution was combined with the nanofiber membrane by coating and then cross-linked by ultraviolet light, finally forming a nanofiber membrane wrapped with ROS-responsive hydrogel.
[0090] Effect example
[0091] The rotator cuff patch prepared in the above example is co-cultured with mouse mesenchymal stem cells (C3H10), comprising the following steps:
[0092] (1) Trim the rotator cuff patch to 1 cm 2 Big small pieces.
[0093] (2) The materials were cultured together in an incubator (humidity above 95%, temperature 37°C, carbon dioxide concentration 5%).
[0094] (3) Detection time points: 0d, 7d, and 14d. The cells and rotator cuff patch co-culture samples were sent for testing after 0d, 7d, and 14d of culture. The expression of RUX2, ALP, COL1A1, and OCN genes at 0d, 7d, and 14d was detected by qRT-PCR. The results are shown in Tables 1 to 4 and Figure 5 As shown, it can be seen that the RUX2, ALP, COL1A1 and OCN gene expression levels of C3H10 cells not co-cultured with the rotator cuff patch (0D) are lower than those of C3H10 cells co-cultured with the rotator cuff patch (7D and 14D), and the RUX2, ALP, COL1A1 and OCN gene expression levels increase with the increase of the co-culture time, indicating that the rotator cuff patch prepared in the example can promote the expression of RUX2, ALP, COL1A1 and OCN genes related to osteogenic and chondrogenic differentiation.
[0095] Table 1 RUX2 gene expression
[0096]
[0097] Table 2 OCN gene expression
[0098]
[0099] Table 3 Expression of COL1A1 gene
[0100]
[0101] Table 4 ALP gene expression
[0102]
[0103] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A tissue repair biomaterial, characterized in that: It comprises a ROS-responsive hydrogel and a nanofiber membrane, wherein the ROS-responsive hydrogel is coated on the surface of the nanofiber membrane; The ROS-responsive hydrogel comprises a hydrogel and first nanoparticles dispersed in the hydrogel; the first nanoparticles are microspheres in which second nanoparticles and peroxidase are encapsulated by liposomes; the second nanoparticles are microspheres containing M2 macrophage exosomes and perfluorochemicals, and the shell of the second nanoparticles comprises a lactic acid-glycolic acid copolymer and a polysulfide; The fibers constituting the nanofiber membrane are of a core-shell structure, and the core layer contains exosomes derived from bone marrow mesenchymal stem cells.
2. The tissue repair biomaterial according to claim 1, characterized in that: The peroxidase comprises catalase; Optionally, the hydrogel comprises methacryloyl gelatin hydrogel; Optionally, the liposomes comprise phosphatidylcholine, cholesterol and distearoylphosphatidylethanolamine-polyethylene glycol 2000.
3. The tissue repair biomaterial according to claim 2, characterized in that: The first nanoparticles are prepared according to the following method: The perfluorochemical solution containing M2 macrophage exosomes is mixed with lactic acid-glycolic acid copolymer and polysulfide, emulsified and ultrasonically treated to form a water-in-oil-in-water double emulsion, and the second nanoparticles formed in the system are separated and collected; The liposome containing catalase is prepared by a thin film dispersion method, and then mixed and incubated with the second nanoparticles to obtain the first nanoparticles.
4. The tissue repair biomaterial according to claim 1, characterized in that: The nanofiber membrane is an electrospun nanofiber membrane; Optionally, the exosomes of bone marrow mesenchymal stem cells are modified with cholesterol and chondrocyte targeting peptide; Optionally, the core layer of the electrospun nanofiber membrane contains a water-soluble polymer loaded with mesenchymal stem cell-derived exosomes; Optionally, the water-soluble polymer comprises hyaluronic acid; Optionally, the shell layer of the electrospun nanofiber membrane contains poly-L-lactic acid and N,N-dimethylformamide.
5. The tissue repair biomaterial according to claim 4, characterized in that: The electrospun nanofiber membrane is prepared according to the following method: exosomes are loaded on hydrosol nanoparticles, and then the hydrosol nanoparticles loaded with exosomes are dispersed in an electrospinning solution, and an electrospun fiber membrane with a core-shell structure is obtained by electrospinning; the hydrosol nanoparticles are composed of the water-soluble polymer in the aqueous medium.
6. The method for preparing a tissue repair biomaterial according to any one of claims 1 to 5, characterized in that: include: (A) mixing a perfluorochemical solution containing M2 macrophage exosomes with a lactic acid-glycolic acid copolymer and a polysulfide, emulsifying and ultrasonicating to form a water-in-oil-in-water double emulsion, separating and collecting the second nanoparticles formed in the system; preparing liposomes containing catalase by a thin film dispersion method, and then mixing and incubating with the second nanoparticles to obtain the first nanoparticles; (B) loading exosomes onto hydrosol nanoparticles, dispersing the hydrosol nanoparticles loaded with exosomes into an electrospinning solution, and obtaining a nanofiber membrane with a core-shell structure by electrospinning, wherein the hydrosol nanoparticles are composed of the water-soluble polymer in the aqueous medium; (C) mixing the first nanoparticles prepared in step (A) with the hydrogel, and then placing the nanofiber membrane in the hydrogel to obtain a nanofiber membrane coated with the ROS-responsive hydrogel.
7. The preparation method according to claim 6, characterized in that: The step (B) comprises emulsifying the mixture of hyaluronic acid and exosomes of bone marrow mesenchymal stem cells into an oil-in-water emulsion, and adding poly-L-lactic acid and N,N-dimethylformamide into the emulsion to obtain an electrospinning solution; Optionally, the electrospinning conditions include: a spinning voltage of 12 kV, a spinning needle diameter of 0.9 mm, a spinning solution flow rate of 0.8 mL / h, and a receiving distance of 15 cm.
8. The preparation method according to claim 6, characterized in that: The hydrogel is a methacryloyl gelatin hydrogel, and the preparation method comprises adding the first nanoparticles into a methacryloyl gelatin hydrogel solution containing a photoinitiator, and then performing cross-linking by ultraviolet light irradiation.
9. Use of the tissue repair biomaterial according to any one of claims 1 to 5, or the preparation method according to any one of claims 6 to 8 in the preparation of tissue or organ damage repair products.
10. Rotator cuff injury repair product, characterized in that: Contains (i) or (ii): (i) the tissue repair biomaterial according to any one of claims 1 to 5; (ii) the ROS-responsive hydrogel as described in any one of claims 1 to 5, and the nanofiber membrane as described in any one of claims 1 to 5; Optionally, the rotator cuff injury repair product includes a rotator cuff patch.
Citation Information
Patent Citations
Composite scaffold material based on electrospinning yarn and hydrogel and preparation method thereof
CN108175874A
Nano enzyme cascade bioreactor (MEGR) and preparation method and application thereof
CN113930335A
Application of cartilage injury treatment preparation and M2 bone marrow macrophage source exosome in preparation of cartilage injury treatment preparation
CN116115641A
Composite hydrogel stent for regeneration and repair of joint disc and preparation method of composite hydrogel stent
CN117065100A
Reactive oxygen species (ROS)-responsive compositions and methods thereof
US20160175265A1
Cited By
Active oxygen responsive nano piperonyl butoxide synergist compound and application of active oxygen responsive nano piperonyl butoxide synergist compound in improving aphid prevention and control effect of efficient cypermethrin
CN122642415A
Active oxygen response nano-piperonyl butoxide synergist complex and application in synergistic high-efficiency cypermethrin control effect on aphids
CN122642415B
